Virios Therapeutics (VIRI) Tops Q1 EPS by 8c

Virios Therapeutics (NASDAQ: VIRI) reported Q1 EPS of ($0.08), $0.08 better than the analyst estimate of ($0.16).

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

You May Also Be Interested In

• Kura Sushi (KRUS) Tops Q3 EPS by 3c; offers outlook
• Southwest (LUV) PT Raised to $60 at Argus
• RBC Capital Starts Shawbrook Group plc (SHAW:LN) at Outperform